Chongqing Pharmaceutical (Group) Co., Ltd. announced that it has issued 20,779,221 shares at an issue price of CNY 19.25 per share for gross proceeds of CNY 400,000,004.25 in a round of funding recently on January 7, 2022. The transaction included participation form returning investor C.Q. Pharmaceutical Holding Co., Ltd. for 99.95% stake. The investor had 99.94% stake before transaction.

The company will have new registered capital of CNY 20,775,586 and rest for capital reserve. The company's registered capital has increased from CNY 449,837,193 to CNY 470,612,779. The transaction has been reviewed and approved by the board of directors and the general meeting of shareholders of the company and does not need to be submitted to the company's board of directors or the general meeting of shareholders for consideration and approval.

The company obtained Business License.